Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics after multiple doses of an inhaled DNAzyme solution delivered by nebulisation in healthy mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DNAzyme Solution for Nebulisation (DNAzyme)

Snippet

Sponsor: Sterna Biologicals GmbH & Co. KG | Conditions: Asthma | Phase 1 | Status: COMPLETED